Electromed (NYSE:ELMD) Stock Rating Lowered by StockNews.com

Electromed (NYSE:ELMD) was downgraded by equities researchers at StockNews.com from a “strong-buy” rating to a “buy” rating in a research note issued to investors on Thursday.

Electromed Stock Up 2.7 %

Shares of NYSE:ELMD traded up $0.82 during midday trading on Thursday, reaching $31.12. The company’s stock had a trading volume of 107,788 shares, compared to its average volume of 95,098. The stock has a fifty day moving average of $28.40 and a 200 day moving average of $21.41. Electromed has a twelve month low of $9.90 and a twelve month high of $31.88. The firm has a market capitalization of $263.21 million, a PE ratio of 43.22 and a beta of 0.31.

Electromed (NYSE:ELMD) last announced its quarterly earnings results on Tuesday, November 12th. The company reported $0.16 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.03 by $0.13. Electromed had a return on equity of 15.32% and a net margin of 11.34%. The company had revenue of $14.67 million during the quarter.

Insider Buying and Selling

In other news, Director Andrew Summers sold 17,463 shares of the business’s stock in a transaction dated Monday, December 2nd. The shares were sold at an average price of $30.09, for a total transaction of $525,461.67. Following the transaction, the director now owns 189,838 shares of the company’s stock, valued at approximately $5,712,225.42. The trade was a 8.42 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. 14.00% of the stock is currently owned by insiders.

Institutional Trading of Electromed

A number of hedge funds and other institutional investors have recently modified their holdings of the business. Wilmington Savings Fund Society FSB purchased a new stake in Electromed during the 3rd quarter worth approximately $226,000. Barclays PLC acquired a new position in shares of Electromed in the third quarter worth $215,000. State Street Corp increased its position in shares of Electromed by 14.5% during the third quarter. State Street Corp now owns 22,066 shares of the company’s stock worth $474,000 after acquiring an additional 2,800 shares during the period. Walleye Capital LLC acquired a new stake in shares of Electromed in the third quarter valued at $274,000. Finally, Pekin Hardy Strauss Inc. boosted its holdings in Electromed by 9.9% in the third quarter. Pekin Hardy Strauss Inc. now owns 38,185 shares of the company’s stock valued at $820,000 after purchasing an additional 3,435 shares during the period. 40.82% of the stock is owned by institutional investors and hedge funds.

Electromed Company Profile

Electromed, Inc develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. The company offers SmartVest airway clearance system for patients with compromised pulmonary functions, including bronchiectasis and cystic fibrosis, as well as neuromuscular conditions, such as cerebral palsy and amyotrophic lateral sclerosis; SmartVest SQL System; SmartVest Clearway System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall; and SmartVest Connect, a wireless technology that allows data connection between physicians and patients to track therapy performance and collaborate in treatment decisions.